National Health Investors, Inc. $NHI Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. reduced its position in shares of National Health Investors, Inc. (NYSE:NHI) by 1.5% during the second quarter, Holdings Channel.com reports. The fund owned 471,670 shares of the real estate investment trust’s stock after selling 7,230 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in National Health Investors were worth $33,074,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. Smartleaf Asset Management LLC boosted its position in shares of National Health Investors by 49.8% in the 1st quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust’s stock valued at $33,000 after purchasing an additional 147 shares during the period. M&T Bank Corp boosted its position in shares of National Health Investors by 4.4% in the 1st quarter. M&T Bank Corp now owns 3,969 shares of the real estate investment trust’s stock valued at $293,000 after purchasing an additional 168 shares during the period. Vident Advisory LLC boosted its position in shares of National Health Investors by 1.6% in the 1st quarter. Vident Advisory LLC now owns 12,691 shares of the real estate investment trust’s stock valued at $938,000 after purchasing an additional 201 shares during the period. Xponance Inc. boosted its position in shares of National Health Investors by 11.2% in the 1st quarter. Xponance Inc. now owns 3,334 shares of the real estate investment trust’s stock valued at $246,000 after purchasing an additional 337 shares during the period. Finally, NewEdge Advisors LLC boosted its position in shares of National Health Investors by 28.7% in the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares during the period. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Stock Down 1.0%

Shares of NHI stock opened at $75.06 on Wednesday. The stock’s 50 day simple moving average is $77.13 and its 200 day simple moving average is $74.34. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91. National Health Investors, Inc. has a twelve month low of $65.13 and a twelve month high of $82.32. The company has a market capitalization of $3.56 billion, a price-to-earnings ratio of 23.98, a PEG ratio of 3.41 and a beta of 0.77.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.16 by $0.06. The business had revenue of $70.27 million for the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. National Health Investors’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the company posted $1.18 earnings per share. As a group, research analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.68 annualized dividend and a yield of 4.9%. This is a positive change from National Health Investors’s previous quarterly dividend of $0.90. National Health Investors’s payout ratio is presently 117.57%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on NHI shares. Wedbush upgraded National Health Investors to a “strong-buy” rating in a research report on Wednesday, July 2nd. National Bankshares set a $90.00 price target on National Health Investors in a research report on Wednesday, October 1st. Cantor Fitzgerald started coverage on National Health Investors in a research report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price target for the company. Truist Financial increased their price target on National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a research report on Friday, August 15th. Finally, KeyCorp upgraded National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 price target for the company in a research report on Thursday, July 10th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $84.83.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.